Cytoreductive Surgery in the Management of Newly Diagnosed Glioblastoma in Adults: A Systematic Review and Evidence‑based Clinical Practice Guideline Update
Glioblastoma (GBM) continues to be a challenging disease to treat, often with rapid progression and limited overall survival. Surgical resection is central to treatment paradigms in combination with radiation therapy and chemotherapy for treatment of newly diagnosed glioblastoma. Authors discuss the evidence in newly available literature since the original guideline was published in 2008, and the recent updates to the recommendations regarding cytoreductive surgery.
Click here to access the guideline.